Correlation Between Pharmala Biotech and Tryp Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmala Biotech and Tryp Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmala Biotech and Tryp Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmala Biotech Holdings and Tryp Therapeutics, you can compare the effects of market volatilities on Pharmala Biotech and Tryp Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmala Biotech with a short position of Tryp Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmala Biotech and Tryp Therapeutics.

Diversification Opportunities for Pharmala Biotech and Tryp Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pharmala and Tryp is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmala Biotech Holdings and Tryp Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tryp Therapeutics and Pharmala Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmala Biotech Holdings are associated (or correlated) with Tryp Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tryp Therapeutics has no effect on the direction of Pharmala Biotech i.e., Pharmala Biotech and Tryp Therapeutics go up and down completely randomly.

Pair Corralation between Pharmala Biotech and Tryp Therapeutics

If you would invest (100.00) in Tryp Therapeutics on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Tryp Therapeutics or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pharmala Biotech Holdings  vs.  Tryp Therapeutics

 Performance 
       Timeline  
Pharmala Biotech Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pharmala Biotech Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Pharmala Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Tryp Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tryp Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tryp Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pharmala Biotech and Tryp Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmala Biotech and Tryp Therapeutics

The main advantage of trading using opposite Pharmala Biotech and Tryp Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmala Biotech position performs unexpectedly, Tryp Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tryp Therapeutics will offset losses from the drop in Tryp Therapeutics' long position.
The idea behind Pharmala Biotech Holdings and Tryp Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges